Back to today’s briefing

Story perspectives

Trump's HALT Fentanyl Act Sparks Controversy Over Research Concerns

7/17/2025

31 2

Summary

Story summary

President Trump has enacted the HALT Fentanyl Act, a decisive move to permanently categorize fentanyl-related substances as Schedule I drugs. While this bipartisan effort seeks to curb trafficking, it has drawn criticism for insufficient public health funding and concerns that it may hinder vital research. Critics emphasize that without robust support for treatment and prevention, the law may fall short in reducing overdose rates.

1 of 1

Story summary

President Trump has enacted the HALT Fentanyl Act, a decisive move to permanently categorize fentanyl-related substances as Schedule I drugs. While this bipartisan effort seeks to curb trafficking, it has drawn criticism for insufficient public health funding and concerns that it may hinder vital research. Critics emphasize that without robust support for treatment and prevention, the law may fall short in reducing overdose rates.